BBIO
BridgeBio Pharma, Inc.Company with tickers: BBIO
CIK
1743881
CUSIP
10806X102
Shares Outstanding
195,861,242
13F Activity (30d)
253 filings
248 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-01-07 | 2019-12-31 | |
| 8-K | 2020-02-19 | 2020-02-12 | |
| 8-K | 2020-03-02 | — | |
| 10-K | 2020-03-03 | 2019-12-31 | |
| 8-K | 2020-03-04 | — | |
| 8-K | 2020-03-06 | 2020-03-04 | |
| 8-K | 2020-03-10 | 2020-03-04 | |
| 8-K | 2020-03-24 | — | |
| 8-K | 2020-04-29 | 2020-04-27 | |
| 8-K | 2020-05-13 | — | |
| 10-Q | 2020-05-14 | 2020-03-31 | |
| 8-K | 2020-06-08 | 2020-06-02 | |
| 8-K | 2020-06-24 | 2020-06-23 | |
| 8-K | 2020-08-11 | — | |
| 10-Q | 2020-08-11 | 2020-06-30 | |
| 8-K | 2020-09-29 | — | |
| 8-K | 2020-10-05 | — | |
| 8-K | 2020-10-06 | 2020-10-05 | |
| 8-K | 2020-10-23 | 2020-10-21 | |
| 10-Q | 2020-11-05 | 2020-09-30 | |
| 8-K | 2020-11-05 | — | |
| 8-K | 2020-11-06 | — | |
| 8-K | 2021-01-04 | 2020-12-31 | |
| 8-K | 2021-01-12 | — | |
| 8-K | 2021-01-20 | 2021-01-19 | |
| 8-K | 2021-01-26 | 2021-01-25 | |
| 8-K | 2021-01-26 | — | |
| 8-K | 2021-01-29 | 2021-01-25 | |
| 8-K | 2021-02-17 | 2021-02-11 | |
| 10-K | 2021-02-25 | 2020-12-31 | |
| 8-K | 2021-02-26 | 2021-02-25 | |
| 8-K | 2021-03-31 | 2021-03-29 | |
| 8-K | 2021-04-15 | 2021-04-13 | |
| 10-Q | 2021-05-06 | 2021-03-31 | |
| 8-K | 2021-05-11 | — | |
| 8-K | 2021-05-14 | 2021-05-06 | |
| 8-K | 2021-06-01 | — | |
| 8-K | 2021-06-22 | 2021-06-17 | |
| 10-Q | 2021-08-05 | 2021-06-30 | |
| 8-K | 2021-08-13 | 2021-08-05 | |
| 8-K | 2021-08-23 | 2021-08-17 | |
| 8-K | 2021-10-26 | 2021-10-23 | |
| 8-K | 2021-11-04 | — | |
| 10-Q | 2021-11-04 | 2021-09-30 | |
| 8-K | 2021-11-18 | 2021-11-17 | |
| 8-K | 2021-12-16 | 2021-12-15 | |
| 8-K | 2021-12-27 | — | |
| 8-K | 2022-02-24 | — | |
| 10-K | 2022-02-25 | 2021-12-31 | |
| 10-Q | 2022-05-05 | 2022-03-31 |
Showing 1–50 of 118 filings